Supriya Lifescience Limited

SUPRIYA.NS·NSE

Compare

842.60−30.65 (−3.51%)today

At close: Oct 21, 3:30 PM IST · May be delayed up to 15 min · INR

Key statistics

Previous close873.25

Open873.25

Day range835.05874.85

52-week range545.501,085.00

Off day high−3.69%

Off 52-week high−22.34%

Volume167.88K

Avg. volume (3M)304.60K

Market cap67.81B

EPS (TTM)24.65

Forward P/E21.72

P/E ratio (TTM)34.18

Dividend yield0.11% (1.00)

Beta (5Y)—

Shares outstanding80.48M

Short interest—

Earnings dateAug 8, 2025

Analyst target—

Profit margin—

Against its peers

Compare in full ›

	SUPRIYA.NS	CONCORDBIO.NS	UCB.BR	1177.HK	1777.TWO	688177.SS
Market cap	67.81B	132.86B	40.61B	95.24B	3.38B	7.37B
P/E (TTM)	34.2	43.7	18.8	35.7	10.2	—
Forward P/E	21.7	29.8	15.4	17.0	—	-26.2
Price/book	5.7	6.6	3.5	2.5	1.3	59.5
Dividend yield	0.11%	0.59%	0.66%	2.59%	5.31%	—
1-year change	+15.79%	−15.54%	−10.65%	−25.00%	+0.40%	−33.37%
Today	−3.51%	−1.23%	−2.74%	−0.93%	+0.53%	−0.56%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to SUPRIYA.NS's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
Concord Biotech LimitedCONCORDBIO.NS · Biotechnology	132.86B	1,270.00	−1.23%
UCB SAUCB.BR · Biotechnology	40.61B	213.00	−2.74%
Sino Biopharmaceutical Limited1177.HK · Biotechnology	95.24B	5.350	−0.93%
SYN-TECH Chem. & Pharm. Co., Ltd.1777.TWO · Biotechnology	3.38B	75.80	+0.53%
Bio-Thera Solutions, Ltd.688177.SS · Biotechnology	7.37B	17.79	−0.56%
SK Biopharmaceuticals Co., Ltd.326030.KS · Biotechnology	5.87T	75,000.00	+0.67%
PreveCeutical Medical Inc.PREV.CN · Biotechnology	12.76M	0.0200	0.00%
Morepen Laboratories LimitedMOREPENLAB.NS · Drug Manufacturers - Specialty & Generic	63.24B	115.42	−5.00%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All SUPRIYA.NS news ›

Business Upturn·Oct 13Positive

Supriya Lifescience receives 'Strong' rating from CRISIL ESG Ratings & Analytics

Supriya Lifescience Limited, a government recognised export house headquartered in Mumbai, has been awarded an 'ESG 65' rating in the 'Strong' category by CRISIL ESG Ratings & Analytics Limited. This recognition underscores the company's…

Kalkine India·Oct 12

Supriya Lifescience NSE:SUPRIYA Reg 74(5) Compliance Certificate Q2 FY27

Kalkine India Supriya Lifescience (NSE:SUPRIYA): What Does the Reg 74(5) Certificate Mean for Shareholders? Source: Krish Capital Pty Ltd Supriya Lifescience Limited (NSE:SUPRIYA) submitted to the National Stock Exchange of India, on 12…

From articles in the 4Search news index.

Earnings

Reported EPS
Estimate

Next report: Fri, Aug 8, 2025

Quarterly results

Financials ›

Revenue
Net income
Net margin 12.7% (Q2 '26)

Prices may be delayed up to 15 min. Not investment advice.

Track record

Leaderboard ›

Days on the list	30 d	1 yr	Best
Trending	0	0	—

Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).

Not eligible for Small-cap gainers, Aggressive small caps (U.S. stocks worth under $2 billion only).

Not eligible for Growth tech (U.S. technology stocks only).

Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).

A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.